First human trial of COVID-19 vaccine finds it is safe and induces rapid immune response

Posted · Add Comment

A study of 108 adults finds that the vaccine produced neutralizing antibodies and T-cell response against SARS-CoV-2, but further research is needed to confirm whether the vaccine protects against SARS-COV-2 infection.

This full article appears on <a href="">Science Daily</a>

Leave a Reply

Your email address will not be published. Required fields are marked *